| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
1 company
Southpoint Capital Advisors LP is 10% Owner at FENC.
Historically, Southpoint Capital Advisors LP's trades have earned a below-average insider score of 47/100 across 7 rated trades. Over a 12-month horizon, none of those trades were profitable, with an average 12-month return of -13.1%.
The FENC filings lean toward selling, a net 1,252,473 shares.
Southpoint Capital Advisors LP has 5 Form 4 filings on record from May 2020 to December 2025, all as 10% Owner at Fennec Pharmaceuticals (FENC), 2020–2025.
The 8 reported transactions were 7 open-market sales and 1 open-market purchase.
Counted by filing, the open-market trades come to 1 purchase worth about $500K and 4 sales worth about $10.3M.
The only open-market purchase was 80,000 shares of FENC at an average $6.25 on May 4, 2020, about $500K.
The largest open-market sale was 1,000,000 shares of FENC at an average $7.50 on December 24, 2025, about $7.5M.
None of the 4 sales since April 2023 was marked as made under a Rule 10b5-1 trading plan.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 24, 2025 | FENC Fennec Pharmaceuticals Inc. | 10% Owner | Sell | 1,000,000 | $7.50 | $7,500,000.00 | -26.7% | -21.5% | - | |
| Nov 18, 2025 | FENC Fennec Pharmaceuticals Inc. | 10% Owner | Sell | 19,341 | $8.79 | $170,048.01 | -0.5% | -0.8% | - | |
| Nov 17, 2025 | FENC Fennec Pharmaceuticals Inc. | 10% Owner | Sell | 246,018 | $8.27 | $2,035,625.21 | -6.1% | -0.8% | - | |
| Oct 9, 2025 | FENC Fennec Pharmaceuticals Inc. | 10% Owner | Sell | 67,114 | $9.48 | $636,228.85 | -1.6% | -18.5% | +14.8% | |
| May 4, 2020 | FENC Fennec Pharmaceuticals Inc. | 10% Owner | Buy | 80,000 | $6.25 | $500,000.00 | +2.0% | - | - |